Department of Pharmaceutical Chemistry, School of Pharmacy, The University of Kansas, Lawrence, Kansas 66047, USA.
J Biol Chem. 2010 Feb 12;285(7):4983-94. doi: 10.1074/jbc.M109.037622. Epub 2009 Dec 10.
The rare neurodegenerative disease Niemann-Pick Type C (NPC) results from mutations in either NPC1 or NPC2, which are membrane-bound and soluble lysosomal proteins, respectively. Previous studies have shown that mutations in either protein result in biochemically indistinguishable phenotypes, most notably the hyper-accumulation of cholesterol and other cargo in lysosomes. We comparatively evaluated the kinetics of [(3)H]dextran release from lysosomes of wild type, NPC1, NPC2, and NPC1/NPC2 pseudo-double mutant cells and found significant differences between all cell types examined. Specifically, NPC1 or NPC2 mutant fibroblasts treated with NPC1 or NPC2 siRNA (to create NPC1/NPC2 pseudo-double mutants) secreted dextran less efficiently than did either NPC1 or NPC2 single mutant cell lines, suggesting that the two proteins may work independently of one another in the egress of membrane-impermeable lysosomal cargo. To investigate the basis for these differences, we examined the role of NPC1 and NPC2 in the retrograde fusion of lysosomes with late endosomes to create so-called hybrid organelles, which is believed to be the initial step in the egress of cargo from lysosomes. We show here that cells with mutated NPC1 have significantly reduced rates of late endosome/lysosome fusion relative to wild type cells, whereas cells with mutations in NPC2 have rates that are similar to those observed in wild type cells. Instead of being involved in hybrid organelle formation, we show that NPC2 is required for efficient membrane fission events from nascent hybrid organelles, which is thought to be required for the reformation of lysosomes and the release of lysosomal cargo-containing membrane vesicles. Collectively, these results suggest that NPC1 and NPC2 can function independently of one another in the egress of certain membrane-impermeable lysosomal cargo.
尼曼-匹克 C 型(NPC)是一种罕见的神经退行性疾病,由 NPC1 或 NPC2 中的突变引起,分别为膜结合和可溶性溶酶体蛋白。先前的研究表明,这两种蛋白的突变导致生化上无法区分的表型,最显著的是胆固醇和其他货物在溶酶体中的过度积累。我们比较评估了野生型、NPC1、NPC2 和 NPC1/NPC2 伪双突变细胞的 [(3)H]葡聚糖从溶酶体中的释放动力学,发现所有被检查的细胞类型之间存在显著差异。具体而言,用 NPC1 或 NPC2 siRNA(创建 NPC1/NPC2 伪双突变体)处理 NPC1 或 NPC2 突变型成纤维细胞从溶酶体分泌葡聚糖的效率低于 NPC1 或 NPC2 单突变细胞系,表明这两种蛋白可能彼此独立地参与膜不可渗透的溶酶体货物的排出。为了研究这些差异的基础,我们研究了 NPC1 和 NPC2 在溶酶体与晚期内体逆行融合以创建所谓的混合细胞器中的作用,这被认为是货物从溶酶体排出的初始步骤。我们在这里表明,与野生型细胞相比,具有 NPC1 突变的细胞具有显著降低的晚期内体/溶酶体融合率,而具有 NPC2 突变的细胞的融合率与观察到的野生型细胞的融合率相似。我们表明 NPC2 不参与混合细胞器的形成,而是需要 NPC2 来有效地从新生的混合细胞器中进行膜分裂事件,这被认为是溶酶体再形成和释放含有溶酶体货物的膜囊泡所必需的。总的来说,这些结果表明 NPC1 和 NPC2 可以在某些膜不可渗透的溶酶体货物的排出中彼此独立地发挥作用。